ANENT EMPIRICAL ANTIBIOTIC THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA IN VARIOUS CATEGORIES OF PATIENTS
The authors have examined 370 patients with community-acquired pneumonia, mainly caused by pneumococcus, clamydia and mycoplasma. Klebsiella рneumoniae as a marker indicating prognostically unfavourable course of the disease was detected concurrent to associated severe diseases. Initial antibiotic treatment should be chosen with due regard given to regional etiological disease profile. In authors' opinion, Levofloxacin is the most adequate drug intended for treating the communityacquired pneumonia